Home › Burkitt Lymphoma › Colorado › Aurora

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Aurora, CO

Isang pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Aurora. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Nagre-recruitPhase 1

Children's Hospital Colorado, Aurora

Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06173518

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Children's Hospital Colorado, Aurora

366 Days – 46 Years · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06124157

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital Colorado, Aurora

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Nagre-recruitPhase 2

Children's Hospital Colorado, Aurora

365 Days · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Nagre-recruitPhase 1/2

Children's Hospital Colorado, Aurora

31 Days – 30 Years · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04544592

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Children's Hospital Colorado, Aurora

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Nagre-recruitPhase 3

Children's Hospital Colorado, Aurora

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Nagre-recruitPhase 1

Children's Hospital Colorado, Aurora

3 Months – 30 Years · Lahat ng kasarian · Na-update Nob 28, 2025 · NCT06559189

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Nagre-recruitPhase 1/2

University of Colorado - Aurora Cancer Center, Aurora

Edad 15 hanggang 50 · Lahat ng kasarian · Na-update Set 9, 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Nagre-recruitPhase 2

Children's Hospital Colorado, Aurora

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update May 4, 2025 · NCT03509961

Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Aurora

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.